Paper39551973
One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.
Kircik L and 8 others. Int J Dermatol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin. Papers, record 39551973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39551973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acne Vulgaris | Major topic |
| Dermatologic Agents | Major topic |
| Cicatrix | Major topic |
| Holistic Health | Major topic |
| Humans | |
| Treatment Outcome | |
| Patient Satisfaction | |
| Hyaluronic Acid | |
| Dermal Fillers | |
| Retinoids | |
| Nicotinic Acids | |
| Skin Care |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Galderma | PubMed |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18377617 | Intrinsic and extrinsic factors in skin ageing: a review. | Int J Cosmet Sci | 2008 | https://conductscience.org/library/papers/18377617 | PubMed |
| 2 | 22007702 | Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging. | J Dermatolog Treat | 2012 | https://conductscience.org/library/papers/22007702 | PubMed |
| 3 | 38183614 | The Microbiome and Acne: Perspectives for Treatment. | Dermatol Ther (Heidelb) | 2024 | https://conductscience.org/library/papers/38183614 | PubMed |
| 4 | 14572299 | Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. | Am J Clin Dermatol | 2003 | https://conductscience.org/library/papers/14572299 | PubMed |
| 5 | 23441236 | Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? | J Clin Aesthet Dermatol | 2013 | https://conductscience.org/library/papers/23441236 | PubMed |
| 6 | 14746619 | Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. | Br J Dermatol | 2004 | https://conductscience.org/library/papers/14746619 | PubMed |
| 7 | 24931812 | Neuromodulatory and anti-inflammatory ingredient for sensitive skin: in vitro assessment. | Inflamm Allergy Drug Targets | 2014 | https://conductscience.org/library/papers/24931812 | PubMed |
| 8 | 16048760 | Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. | Eur J Dermatol | 2005 | https://conductscience.org/library/papers/16048760 | PubMed |
| 9 | 31524348 | An Advanced, Physician-Strength Retinol Peel Improves Signs of Aging and Acne Across a Range of Skin Types Including Melasma and Skin of Color | J Drugs Dermatol | 2019 | https://conductscience.org/library/papers/31524348 | PubMed |
| 10 | 38140732 | Epidermal barrier function in dry, flaky and sensitive skin: A narrative review. | J Eur Acad Dermatol Venereol | 2024 | https://conductscience.org/library/papers/38140732 | PubMed |
| 11 | 36361857 | Skin Barrier Function and the Microbiome. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361857 | PubMed |
| 12 | 10971324 | Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. | Br J Dermatol | 2000 | https://conductscience.org/library/papers/10971324 | PubMed |
| 13 | 29663317 | Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands. | Br J Dermatol | 2018 | https://conductscience.org/library/papers/29663317 | PubMed |
| 14 | 29974453 | Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene. | Br J Dermatol | 2018 | https://conductscience.org/library/papers/29974453 | PubMed |
| 15 | 30452511 | Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial. | JAMA Facial Plast Surg | 2019 | https://conductscience.org/library/papers/30452511 | PubMed |
| 16 | 33671908 | Gelatin/Chitosan Bilayer Patches Loaded with Cortex Phellodendron amurense/Centella asiatica Extracts for Anti-Acne Application. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/33671908 | PubMed |
| 17 | 29549598 | Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars. | Dermatol Ther (Heidelb) | 2018 | https://conductscience.org/library/papers/29549598 | PubMed |
| 18 | 23467280 | Hyaluronic acid: A key molecule in skin aging. | Dermatoendocrinol | 2012 | https://conductscience.org/library/papers/23467280 | PubMed |
| 19 | 33764577 | Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. | J Eur Acad Dermatol Venereol | 2021 | https://conductscience.org/library/papers/33764577 | PubMed |
| 20 | 16869175 | Recommendation of moisturizers and cleansers: a study of unmet needs among dermatology patients. | Cutis | 2005 | https://conductscience.org/library/papers/16869175 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518881 | Efficacy and Safety Analysis of Concentrated Growth Factor Combined with Photorejuvenation for Sensitive Skin Patients: A Retrospective Cohort Study. | Clin Cosmet Investig Dermatol | 2026 | https://conductscience.org/library/papers/42518881 | PubMed |
| 42075875 | Topical Retinoids in Acne Vulgaris and Acne Scars-From Monotherapy to Combining Regimens. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075875 | PubMed |
| 41949173 | Personalized Approach for Acne Management With Dermocosmetics According to Initial Skin Sensitivity. | J Cosmet Dermatol | 2026 | https://conductscience.org/library/papers/41949173 | PubMed |
| 40932054 | Use of Dermocosmetics in Acne Management: A Middle East-North Africa Consensus. | Int J Dermatol | 2026 | https://conductscience.org/library/papers/40932054 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39551973
GET https://conductscience.org/api/papers/v1/39551973/references?page=2